Skip to main content
Log in

HLA B27: A prognostic factor in juvenile chronic arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study was performed to assess the frequency of HLA B27 in patients with juvenile chronic arthritis (JCA) of varying severity and outcome by studying three patient categories: those in whom cytostatic treatment with azathioprine had been started, those with secondary amyloidosis, and those with arthroplasty of the knee or hip joints. In the first category the frequency of the HLA B27 allele was compared between those who had attained remission and those who had not. In the second and third categories the rate at which amyloidosis developed and the timing for the need of arthroplasty, were compared for HLA B27-positive and-negative patients. A control group consisted of 37 patients with uncomplicated seronegative polyarthritis. Ten of the 37 patients in the control group (27%) were HLA B27 positive as opposed to 84 out of 190 (44%) in the three study groups. Of the 101 patients treated with azathioprine, two out of 15 in remission were HLA B27 positive, whereas as many as 41 out of 86 with still active disease were HLA B27 positive (p=0.013). Of the secondary amyloidosis patients, 29 out of 51 carried HLA B27. The HLA B27-positive patients contracted amyloidosis on average 5.9 (median 6.7) years earlier than the HLA B27-negative patients (p=0.038). Of the arthroplasty patients, 39 out of 91 carried HLA B27. The HLA B27-positive patients underwent arthroplasty on average 2.9 (median 3.5) years earlier than the HLA B27-negative patients (p=0.050). We conclude that HLA B27-positive cases are accumulated among the most severe cases of JCA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rachelevsky GS, Terasaki PI, Katz R, Stiehm ER. Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med 1974;290:892–3.

    PubMed  Google Scholar 

  2. Edmonds J, Morris RI, Metzger AL, et al. Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W27. Ann Rheum Dis 1974;33:289–92.

    PubMed  Google Scholar 

  3. Buc M, Nyulassy S, Stefanovic J, Michalko J, Mozolova D. HL-A system and juvenile rheumatoid arthritis. Tissue Antigens 1974;4:395–7.

    PubMed  Google Scholar 

  4. Hall MA, Ansell BM, James DCO, Zylinski P. HL-A antigens in juvenile chronic polyarthritis (Still's disease). Ann Rheum Dis 1975;34 (suppl.):36–8.

    Google Scholar 

  5. Hill RH. HL-A antigens in juvenile rheumatoid arthritis. Arthritis Rheum 1977;20:498–9.

    Google Scholar 

  6. Gershwin ME, Opelz G, Terasaki PI, Castles JJ, Gorman TA. Frequency of HLA-Dw3 in juvenile rheumatoid arthritis. Tissue Antigens 1977;10:330–6.

    PubMed  Google Scholar 

  7. Dequeker J, Decock T, Walravens M, van de Putte I. A systemic survey of HLA-B27 prevalence in inflammatory rheumatic diseases. J Rheumatol 1978;5:452–9.

    PubMed  Google Scholar 

  8. Mäkelä AL, Tiilikainen A. HLA antigens in children with juvenile rheumatoid arthritis. Laeknabladid 1978;65 (suppl 3):113–5.

    Google Scholar 

  9. Arnett FC, Bias WB, Stevens MB. Juvenile-onset chronic arthritis. Clinical and roentgenographic features of a unique HLA-B27 subset. Am J Med 1980;69:369–76.

    PubMed  Google Scholar 

  10. Morling N, Friis J, Heilmann C, et al. HLA antigen frequencies in juvenile chronic arthritis. Scand J Rheumatol 1985;14:209–16.

    PubMed  Google Scholar 

  11. Schuchmann L, Albert ED, Michels H, Renz K. Differenzierung der Juvenilen Chronischen Arthritis (JCA)-Diagnostiche Bedeutung der HLA Assoziationen. Klin Päd 1984;19:355–9.

    Google Scholar 

  12. Brunner HI, Ivaskova E, Haas P, et al. Class I associations and frequencies of class II HLA-DRB alleles by RELP analysis in children with rheumatoid-factor-negative juvenile chronic arthritis. Rheumatol Int 1993;13:83–8.

    PubMed  Google Scholar 

  13. Miller ML, Aaron S, Jackson J, et al.. HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 1985;28:146–150.

    PubMed  Google Scholar 

  14. Cassidy JT, Levinson JE, Bass JC, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986;29:274–81.

    PubMed  Google Scholar 

  15. Mitsui H, Juji T, Sonozaki H, Seki H., Watanabe N. Distribution of HLA-B27 in patients with juvenile rheumatoid arthritis. Ann Rheum Dis 1977;36:86–7.

    PubMed  Google Scholar 

  16. Nissilä M, Elomaa L, Tiilikainen A. HL-A antigens in juvenile rheumatoid arthritis. N Engl J Med 1975;292:430.

    PubMed  Google Scholar 

  17. Hall PJ, Burman SJ, Barash J, Briggs DC, Ansell BM. HLA and complement C4 antigens in polyarticular onset seronegative juvenile chronic arthritis: association of early onset with HLA-DRw8. J Rheumatol 1989;16:55–9.

    PubMed  Google Scholar 

  18. Bedford PS, Ansell BM, Hall PJ, Woo P. Increased frequency of D4 in children and adults with systemic onset JCA. Clin Exp Rheumatol 1992;10:189–93.

    PubMed  Google Scholar 

  19. Wood PH. Nomenclature and classification of arthritis in children. In: Munthe E. editor. The care of Rheumatic Children. Basel, EULAR;1978:47.

    Google Scholar 

  20. van der Linden SM, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis in HLA B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:241–9.

    PubMed  Google Scholar 

  21. Tiitinen S, Kaarela K, Filipowich-Sosnowska, A, et al. HLA typing and seropositivity in Finnish and in Polish patients with rheumatoid arthritis and amyloidosis. Clin Rheumatol 1992;2:265–8.

    Google Scholar 

  22. Isomäki H, Koota K, Martio J, et al. HL-A27 and arthritis. Ann Clin Res 1975;7:138–45.

    PubMed  Google Scholar 

  23. Leirisalo-Repo M, Suoranta H. Ten-year followup study of patients withYersinia arthritis. Arthritis Rheum 1988;31:533–7.

    PubMed  Google Scholar 

  24. Westman P, Partanen J, Leirisalo-Repo M, Koskimies S. Different DRB1 04 alleles predominate in the Finnish random population and in HLA-B-27-positive sub-populations. Tissue Antigens 1994;44:329–31.

    PubMed  Google Scholar 

  25. Woo P. Amyloidosis in pediatric rheumatic disease. J Rheumatol 1992;19 (suppl. 35):10–6.

    Google Scholar 

  26. Schuchmann L, Michels H, Renaud M, Renz K. Die Amyloidoseeine gefürchtete Folgekrankheit der juvenilen chronischen Arthritis. Klin Päd 1981;193:67–72.

    Google Scholar 

  27. Burmann SJ, Hall PJ, Bedford PA, Howard A, Ansell BM. HLA antigen frequencies among patients with juvenile chronic arthritis and amyloidosis: a brief report. Clin Exp Rheumatol 1986; 4:261–3.

    PubMed  Google Scholar 

  28. Lehtimäki MY, Kaarela K, Hämäläinen MMJ. Incidence of hip involvement and need for total hip replacement in rheumatoid arthritis. Scand J Rheumatol 1986;15:387–91.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Savolainen, H.A., Lehtimäki, M., Kautiainen, H. et al. HLA B27: A prognostic factor in juvenile chronic arthritis. Clin Rheumatol 17, 121–124 (1998). https://doi.org/10.1007/BF01452257

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01452257

Keywords

Navigation